The therapy of T. vaginalis infections was revolutionized by the discovery of metronidazole (Cosar, Julou, and Benazet, 1959) . The course recommended as standard treatment has been 200 mg. orally three times daily for 7 days (Rodin, King, Nicol, and Barrow, 1960) . In a trial by Csonka (1971) Tinidazole (Fasigyn ') has been presented as the most potent member of a new series of nitroimidazoles (Howes, Lynch, and Kivlin, 1970) . Laboratory study of the effect of tinidazole on strains of T. vaginalis from infected patients showed a 1-3 to 8 times higher trichomonicidal effect than that of metronidazole, and the serum level after ingestion of 2 g. in a single dose was similar to that reported for metronidazole (Woodcock, 1972 GROUP I 68 patients were requested not to eat anything during the 4 to 5 hours before they were given 1-6 g. tinidazole (4 tablets of 400 mg.) in a single dose under supervision. They were asked to return after 1 week and again after about 1 month for further cultures. White blood cell counts and transaminase estimations were performed before the administration of the drug and again after one week when the patient had been fasting for 5 hours.
The therapy of T. vaginalis infections was revolutionized by the discovery of metronidazole (Cosar, Julou, and Benazet, 1959) . The course recommended as standard treatment has been 200 mg. orally three times daily for 7 days (Rodin, King, Nicol, and Barrow, 1960) . In a trial by Csonka (1971) , it was shown that, after a single oral dose of 2 g. metronidazole (Flagyl ), an 82 per cent. cure rate was observed compared to 94 per cent. for the standard course. With the same single-dose treatment, Morton (1972) found a recurrence rate, including re-infections, of 18 per cent. and a true cure rate of about 90 per cent. in 118 women followed-up after treatment with metronidazole. Fourteen men were also treated and followed and none had a recurrence.
Tinidazole (Fasigyn ') has been presented as the most potent member of a new series of nitroimidazoles (Howes, Lynch, and Kivlin, 1970) . Laboratory study of the effect of tinidazole on strains of T. vaginalis from infected patients showed a 1-3 to 8 times higher trichomonicidal effect than that of metronidazole, and the serum level after ingestion of 2 g. in a single dose was similar to that reported for metronidazole (Woodcock, 1972) . Liechti (1971) GROUP II 58 patients were given 2 g. tinidazole (4 tablets of 500 mg.) without any restrictions on food intake. They were followed up as above.
Treatment was also given to 40 per cent. of the sexual partners in both groups by providing the patient with 150 mg. tablets of tinidazole for the partner to take twice daily for 1 week.
Diagnosis
Trichomonas vaginalis was isolated within 5 days by culture in Diamond's medium incubated at 370C. (Diamond, 1957) after using Diamond's or Stuart's medium for transport (Wallin, Gnarpe, and Forsgren, 1974) . In all female cases, microscopical examination for trichomonads of wet smears of vaginal discharge was also made within 5 minutes after the collection of the specimen (Eddie, 1968) . Although moist urethral scrapings were examined in male cases, most of the infections were detected only by culture. Results Twelve of 115 women failed to return for further examination and are excluded from the study. The remaining 103 patients attended for the first follow-up test after 4 to 21 days (mean 8 days) and 69 per cent. were also seen a second time after 3 to 15 weeks (mean 6 weeks).
Tinidazole in T. vaginalis. II 149 Table I presents the results of treatment in 103 women. In six women recurrences were considered to be due to treatment failure and in four to reinfection after resumption of intercourse with untreated contacts. Among those given 1-6 g. tinidazole, the failure rate was 7 per cent. compared to 4 per cent. among those given 2 g. Four of the six patients who were considered to be cases of treatment failure were re-treated, two with 1-6 g. and two with 2 g. tinidazole, and one patient in each group failed a second time. The strain of T. vaginalis from one of the latter patients was examined for susceptibility to tinidazole and found to be sensitive. White blood cell counts and transaminase levels were checked before treatment and after 1 week in 85 per cent. of the group which was given 1 -6 g. tinidazole and in 82 per cent. of the group given 2 g. In the second group a differential count was also done before and after treatment. No abnormal values were found.
Discussion
The most important aetiological agent of vaginitis in adult women is Trichomonas vaginalis (Gray and Barnes, 1965) . Epidemiological observations suggest that the disease is usually spread by sexual contact (Robinson, Mirchandani, and Causing, 1965) and many cases present for treatment in venereal diseases clinics. For more than 10 years metronidazole given for 7 days has given satisfactory results. The best way of overcoming the failure of patients to take the treatment prescribed is to give a single dose under supervision. This is also more convenient for the patient than taking two or more pills a day for 1 or 2 weeks. Single doses have for long been the preferred treatment in many clinics for patients with gonococcal infections.
Tests in the laboratory showed tinidazole to be up to eight times more active than metronidazole against strains of T. vaginalis; when the drug was given in a single oral dose the serum level of tinidazole remained above the trichomonicidal level for more than 48 hours .
In the present study we have assessed the effect of tinidazole given in single doses. Excluding four cases of probable re-infection, the true failure rate for 99 adequately observed women was 6 per cent. The best result was obtained in the group given the higher dose (2 g. tinidazole), in which 96 per cent. of the patients were cured. Two of the six women who were cases of treatment failure had condylomata acuminata and one had an acute endometritis. Woodcock (1972) found an apparent relationship between the failure of the 2 g. dose of metronidazole to eradicate trichomonads and the presence of undetected gonorrhoea. However, in our study, none of the six patients classed as treatment failures had a concomitant gonococcal infection compared with a 23 per cent. incidence of gonorrhoea in the whole series. One woman treated twice with 2 g. tinidazole failed to be cured both times even though her strain of T. vaginalis was examined in the laboratory and found to be sensitive to tinidazole. Failure of absorption of the drug could be a possible explanation.
Although only 5 per cent. of the patients in this study were married, 40 per cent. accepted medication to be given to a sexual partner. This manner of treating the partner without examination could be a possible explanation for the low re-infection rate of only 4 per cent. in this study compared to others (Csonka, 1971; Morton, 1972) . Cases recorded as re-infections could, in fact, be treatment failures, as no attempt was made to examine the sexual partners.
As there were no re-infections in Group 
